… October 23, 2025 West Pharmaceutical Services, Inc. beats earnings … updated full year and fourth quarter guidance. As Eric mentioned … $210 million in capital expenditures and remain on track … Q4 organic growth by roughly 360 basis points. In fourth quarter, …

… AAPL) will post its fiscal fourth-quarter results late Thursday. Wall Street … up 7.5%. Fiscal Q4 includes the first couple of … and $72 billion on capital expenditures this year. Earlier this … Biogen (BIIB) and Alnylam Pharmaceuticals (ALNY) will report Q3 …

… for the fourth quarter ended July 26, 2025. Fourth Quarter Highlights Net … in Watchung, NJ Fourth Quarter of Fiscal 2025 Results … or remodeled stores, higher pharmacy sales and inflation in … due primarily to capital expenditures. Interest expense decreased in …

… is Moderate Sell. Telix Pharma rockets after major guidance upgrade … Shares in Telix Pharmaceuticals (ASX: TLX) were up … base – has seen the fourth quarter kick off in a position … development (R&D) expenditure guidance, expecting a year-on …

… RMS early in the fourth quarter of 2025 and … results, early in the fourth quarter of 2025. Systemic Lupus … expenses and capital expenditure requirements into the fourth quarter of 2026, … from large and specialty pharmaceutical and biotechnology companies, many …

… participation), as we enter Q4. But that’s not … optimal processes and reduce capital expenditures…. Reports so far suggest … s all about healthcare—big pharma, wellness centers, vitamin business … FBCG), SPDR S&P Pharmaceuticals (XPH), iShares AI Innovation …

… driven by a strong fourth quarter that saw gross domestic product … of 4.2%. The fourth-quarter growth of 5% compared to … as motor vehicles (126%), pharmaceuticals (52%), and ready-made … fourth quarter, recording a contraction of about 7.4%. On the expenditure …

… Costco Wholesale Corporation Fourth Quarter Fiscal 2025 Earnings Call … the quarter. Capital expenditure in Q4 was approximately $1 … . Within ancillary businesses, pharmacy, optical, and hearing … For example, during the fourth quarter, we launched more relevant …

… the Phase 1 confirmatory pharmacokinetic/pharmacodynamic (PK/PD) … 1 and the pharmacokinetic and pharmacodynamic profile is consistent … study in the fourth quarter of 2025.” The single … expenses and capital expenditure requirements, and those risks …

… Q4 FY 2025, from $14.8 million in the fourth quarter … share in the fourth quarter of the … new drug or pharmaceutical discoveries; adverse economic …             Cash Flows from Investing Activities                 Expenditures for property and equipment     (262 …